National Institutes of Health logo

Single Source for Continuation of the Integrated Islet Distribution Program U24 (Clinical Trial Not Allowed)

National Institutes of Health

Funding Amount

Up to $3,300,000

Deadline

Closed

Number of Awards

1

Grant Type

Federal

Deadline history & next window

Closed — no recurring cycle is stated for this program

Open grants like this one are below.

Cycle
Not stated
Last deadline
September 30, 2026
Tracked since
April 2026

Open now: similar grants

Can we apply?

Check your organization against each line. Taken from the listing; confirm with the funder's guidelines.

Eligible organizations

  • Nonprofits (501(c)(3))
  • Public & Indian housing authorities
  • Public colleges & universities
  • City & township governments
  • School districts
  • County governments
  • Small businesses
  • For-profit businesses

Overview

Notice of Intent to Publish a Funding Opportunity Announcement for Single Source for Continuation of the Integrated Islet Distribution Program (UC4)

The NIDDK, intends to publish a Notice of Funding Opportunity (NOFO) to solicit applications for research on { distributing human islets and is announcing its intent to issue a single source cooperative agreement award to Beckman Research Institute/City of Hope for the currently funded Integrated Islet Distribution Program (IIDP) to renew the program and maintain support for its continuing mission to provide the scientific community with important islet resources for diabetes research. The IIDP facilitates the distribution of human islets to biomedical researchers by establishing partnerships with qualified islet isolation facilities to prepare and distribute human islets. The program manages an application process to establish investigator eligibility to receive islet shipments, informs investigators of islet availability, manages a cost recovery system through fees collected from islet recipients, and oversees standardized phenotypic and genotypic analyses of islet preparations distributed throughout the IIDP network. Human islets remain an essential resource for diabetes research to advance our understanding of human islet cell biology, and to promote the development of new therapies for the prevention and treatment of diabetes}. Applications are not being solicited at this time. Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive projects. This NOFO will utilize the {U24 Resource-Related Research Projects—Cooperative Agreements} activity code. Investigators with expertise and insights into this area of {live cell distribution and human islet biology} are encouraged to begin to consider applying for this new NOFO. In addition, collaborative investigations combining expertise in {coordinating center administration and islet biology} will be encouraged and these investigators should also begin considering applying for this application.

Details

  • Agency: National Institutes of Health
  • Department: Department of Health and Human Services
  • Opportunity #: NOT-DK-26-316
  • Total Funding: $3,300,000
  • Expected Awards: 1
  • Instrument: cooperative_agreement

Focus Areas & Funding Uses

Fields of Work

  • Science research

Categories

Browse similar grants by category

Related Grants

Open grants from this funder and similar programs

Your AI grants department

Ready to apply for Single Source for Continuation of the Integrated Islet Distribution Program U24 (Clinical Trial Not Allowed)?

Grantable helps you assess fit, draft narratives, and track deadlines — so you can submit stronger applications, faster.

You found Single Source for Continuation of the Integrated Islet Distribution Program U24 (Clinical Trial Not Allowed). Now let's win it.

Start writing